Laboratoires Pierre Fabre
Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company headquartered in the city of Castres, Midi-Pyrénées, France.
History
Founded in 1962 by Pierre Fabre, the company is present in over 130 countries.In 1984, Pierre Fabre Dermatologie was founded. In 1986, Pierre Fabre Japan was established as a joint venture with Shiseido. In 1989, vinorelbine received its marketing authorisation. Laboratoires Avène were also created. In 1990, the Avène thermal spa re-opened. The Pierre Fabre Immunology Centre in Saint-Julien-en-Genevois was inaugurated.
Olivier Bohuon was Chief Executive from September 2010 to April 2011.
In December 2014, the Group announced to trade unions the elimination of 551 positions in France and in Barcelona, during a central works council meeting. The Research & Development and Medical Promotion divisions were affected. A strategic plan entitled Trajectoires 2018 was launched. Although promises of internal redeployment were made for employees in Midi-Pyrénées, unions expressed concerns about potential layoffs.
In March 2025, Marie-Andrée Gamache was appointed head of the Pierre Fabre Medical Care division. In the autumn of the same year, the Pierre Fabre Group inaugurated its new headquarters, named "Campus Chartreuse", in Castres.
Business
The company is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products.The company had a consolidated turnover of 1.978 billion euros in 2012.
Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based in France.
Products
Pierre Fabre is best known for its vinorelbine, an anticancer drug of the vinca alkaloid class.They also developed vinflunine, a fluorinated vinca alkaloid derivative available in Australia for "advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum containing regimen."